On Invalid Date, Iradimed (NASDAQ: IRMD) reported Q4 2023 earnings per share (EPS) of $0.36, up 24.14% year over year. Total Iradimed earnings for the quarter were $4.54 million. In the same quarter last year, Iradimed's earnings per share (EPS) was $0.29.
As of Q2 2024, Iradimed's earnings has grown 33.33% year over year. This is 54.2 percentage points lower than the US Medical Devices industry earnings growth rate of 87.53%. Iradimed's earnings in the past year totalled $17.19 million.
What is IRMD's earnings date?
Iradimed's earnings date is Invalid Date. Add IRMD to your watchlist to be reminded of IRMD's next earnings announcement.
What was IRMD's revenue last quarter?
On Invalid Date, Iradimed (NASDAQ: IRMD) reported Q4 2023 revenue of $17.45 million up 17.42% year over year. In the same quarter last year, Iradimed's revenue was $14.86 million.
What was IRMD's revenue growth in the past year?
As of Q2 2024, Iradimed's revenue has grown 23% year over year. This is 13.66 percentage points higher than the US Medical Devices industry revenue growth rate of 9.34%. Iradimed's revenue in the past year totalled $65.56 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.